UNRESECTABLE RENAL CELL CARCINOMA
Clinical trials for UNRESECTABLE RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost: could a probiotic supercharge cancer treatment?
Disease control OngoingThis early-stage study is testing if adding a probiotic called CBM588 to standard cancer drugs (cabozantinib and nivolumab) can help patients with advanced kidney cancer. The probiotic aims to improve the mix of 'good' bacteria in the gut, which might help the body's immune syste…
Matched conditions: UNRESECTABLE RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Personalized immune cells tested to fight five tough cancers
Disease control TerminatedThis early-stage study aimed to test the safety and early effectiveness of a personalized cell therapy called STIL101. The therapy involved growing a patient's own cancer-fighting immune cells (T-cells) from a tumor sample in a lab and then infusing them back. It was designed for…
Matched conditions: UNRESECTABLE RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could daily fasting boost cancer treatment?
Disease control TerminatedThis study aimed to see if time-restricted eating (limiting food to a 10-hour daily window) could improve outcomes for people with advanced head & neck or kidney cancer receiving immunotherapy. Researchers wanted to learn if this eating pattern changes gut bacteria and the body's…
Matched conditions: UNRESECTABLE RENAL CELL CARCINOMA
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug duo tested in fight against rare, aggressive kidney cancer
Disease control OngoingThis study is testing whether combining two cancer drugs works better than using just one to treat an aggressive form of kidney cancer that has spread or cannot be removed by surgery. The trial is enrolling patients of all ages, from children to adults. Researchers want to see if…
Matched conditions: UNRESECTABLE RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC